Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
- DOI
- 10.1593/neo.04316
- Published
- 2004 Sep-Oct
- Container
- Neoplasia (New York, N.Y.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1593/neo.04316,
title = {Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.},
author = {Raffaghello L and Prigione I and Airoldi I and Camoriano M and Levreri I and Gambini C and Pende D and Steinle A and Ferrone S and Pistoia V},
year = {2004},
journal = {Neoplasia (New York, N.Y.)},
doi = {10.1593/neo.04316},
url = {https://doi.org/10.1593/neo.04316}
}RIS
TY - JOUR TI - Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. AU - Raffaghello L AU - Prigione I AU - Airoldi I AU - Camoriano M AU - Levreri I AU - Gambini C AU - Pende D AU - Steinle A AU - Ferrone S AU - Pistoia V PY - 2004 JO - Neoplasia (New York, N.Y.) DO - 10.1593/neo.04316 UR - https://doi.org/10.1593/neo.04316 ER -
APA
L, R., I, P., I, A., M, C., I, L., C, G., D, P., A, S., S, F., & V, P. (2004). Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.. Neoplasia (New York, N.Y.). https://doi.org/10.1593/neo.04316
Source records
- pubmed · retrieved 2026-09-26T19:11:47.755Z